Dystrophic and nondystrophic myopathias can be identified mainly according to their clinical and electrophysiological feature. sharing the symptom of myotonia. that is a delayed relaxation of muscle filAbstracts: Thirteenth Internation a l \\-inler-W,) rk,h op on Biochemical and Clinical Aspects of Pteridines 67 aments following contraction or mech anical and electrical stimulation. Dystrophic muscle diseases are accompanied by more or less Se\ere muscle wasting. which can be detected by examination of muscle biopsy material or by estimation of soluble. cytosolic and insoluble, structurally bound contractile muscular proteins in serum of patients. In cases of severe damage of myocytes, the degradation of plasma membranes of myocytes is associated by an activation of lysosomal proteolytic enzymes causing degradation and release of myogenic contractile proteins into the circulation.
Previous work has shown that inhibition of tetrahydrobiopterin biosynthesis by 2,4-diamino-6-hydroxy pyrimidine attenuates the turnover of nitric oxide synthase in cultured cells. Comparatively high doses of sepiapterin derived tetrahydrobiopterin are required to counteract the effect of the inhibitor. Distinct subcellular distribution of induced nitric oxide synthase, biosynthesis of tetrahydrobiopterin from guanosine 5'-triphosphate (GTP) and sepiapterin, respectively, might be a possible cause of this behaviour (I) . As a first step in the study of subcellular distribution of pteridine biosynthesis in comparison with nitric oxide synthase activity, we investigated activities of GTP-cyclohydrolase I (E.c. 3.6.4.16), 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase (E.c. 1.1.1.53) in cytosolic and microsomal fractions of J774A.l murine macrophages, and compared these with nitric oxide synthase activities. Cells were treated with E. coli lipopolysaccharide and interferon cells gamma for 24 hours, homogenized by sonication and centrifuged at 12000 g. The supernatant was then separated into cytosolic and microsomal fractions by centrifugation at 100000 g. The purity of the fractions exceeded 85% as tested by lactate dehydrogenase and cytochrome c reductase activities. Nitric oxide synthase activity was Pteridines / Vol. 5 / No. 2 found in both microsomal and cytosolic fractions, as had also been observed previously (2) . Tetrahydrobiopterin biosynthesis activities, in contrast, were exclusively present in the cytosolic fraction.
I. Werner-Felmayer. G , Werner The aetiology and pathogenesis of Behcet's Disease (BD) are unknown, however an immunologic pathogenesis is strongly possible. There are many conflicting data on the subject. BD is a chronic inflammatory multisystemic disorder clinically characterized by recurrent oral and genital ulceration with inflammatory ocular disease, vasculitis and with neurological manifestations. The changings in suppressor cell activity have been found in autoimmune diseases. Additionally, enhanced urinary neopterin levels in the diseases have been also detected. As it is well known that recently, it has been suggested that neopterin in biological fluids, especially in urine is a useful biomarker for activation of cell-mediated immunity. Some clinical similarities of BD with autoimmune diseases have been described. Therefore, in the present study, urinary neopterin levels have been determined with HPLC in the active and/or inactive stages of BD.
The results will be discussed. Previous studies showed that serum neopterin concentrations increased with the time after death and serum neopterin concentrations were higher in cases with inflammatory disorders compared to those without. Formation of neopterin and degradation of tryptophan correlated with each other suggesting an immune mediated background because both metabolic pathways are inducible by cytokines. The present study was initiated to further explore mechanisms involved in neopterin formation after death. We examined concentrations of soluble TNF receptor type 55 (sTNFR) after death in addition to neopterin. kynurenine and tryptophan concentrations in serum and cerebrospinal fluid samples of 58 corpses. 36 males. 22 females. Mean age was 57 years. range: 4 months -90 years. Samples were taken within 2 and 75 hours after death during autopsy and were stored at -20°C until measurement. Neopterin. tryptophan and kynurenine were measured by HPLC with on-line deproteinization: Neopterin (353 nm excitation and 438 nm emission wavelength) and tryptophan (285 nm excitation and 360 nm emission wavelength) were measured by their native fluorescence. Kynurenine was measured by UV-absorption at 365 nm wavelength. sTNFR was measured by ELISA (T Cell Sciences). Concentrations of all analytes in the serum of corpses were considerably increased. except of tryptophan. Compared to normal values average neopterin and sTNFR concentrations were more than IO-fold higher. Also in CSF all anal:Y1es were increased compared to CSF levels in controls after lumbal puncture. There existed various .; ignificant correlations between concentrations of : 1~opterin and kynurenine. sTNFR and tryptophan in serum and also in the CSF. Associations between neopterin. kynurenine and sTNFR suggest an immune-mediated background. However. increase of kynurenine to be due to immune-related degradation of tryptophan could not be unequivocally verified because tryptophan levels tended to increase after death too and correlated to neopterin and sTNFRs as well as kynurenine. Increase of tryptophan may indicate a more general increase of concentrations of a variety of substances after death. When relating concentrations of analytes to tryptophan levels, there existed no longer any correlation with time after death and with age for both. serum and CSF. In contrast, the associations between concentrations of analy1es related to tryptophan remained to be significant in serum and CSF: Neopterin related to tryptophan correlates strongly to kynurenine per tryptophan. and a similar strong association existed e.g. between neopterin and sTNFR in serum when both analy1es were related to tryptophan. Thus, the data still indicate to a role of immunological involvement in neopterin and sTNFRs production after death. From our data we may conclude that the likely sequence of events involved in post-mortem changes of neopterin concentrations are: After death there is no longer renal elimination of neopterin, it thus accumulates in serum when there is still production of neopterin from metabolically active cells after death. Likewise. in hemodialysis partients extremly high serum neopterin concentrations are common.
reaching similar values as in corpses after death. At presents it is unclear whether fonnation of neopterin is additionally stimulated after death by e.g. hypoxia. Rather it is the case that delayed shut off of anabolic events can explain the increase of neopterin and other parameters of this study after death. the association between changes of neopterin and of other immune-related products may simply result from the close relationship between metabolic cascades influenced by immune activation.
aments following contraction or mech anical and electrical stimulation. Dystrophic muscle diseases are accompanied by more or less Se\ere muscle wasting. which can be detected by examination of muscle biopsy material or by estimation of soluble. cytosolic and insoluble, structurally bound contractile muscular proteins in serum of patients. In cases of severe damage of myocytes, the degradation of plasma membranes of myocytes is associated by an activation of lysosomal proteolytic enzymes causing degradation and release of myogenic contractile proteins into the circulation. In this study we addressed several issues: A potiential role of the immune system in the pathogenesis of non dystrophic and dystrophic myopathias, the feasibility to differentiate myopathias by serum neopterin concentrations and the connection between alterations of neopterin and muscular protein concentrations in serum of patients with myopathias. We conducted measurements of soluble muscular proteins as creatine-kinase, its isoenzym CKMB. lactate-dehydrogenase. alphahydroxybutyrate-dehydrogenase and myoglobin, insoluble muscular proteins troponin-T and myosin-heavy chain fragments and neopterin in sera of 8 children (age: 11 + /-2.45 years) with genetically verified M. Duchenne. an Xchromosome linked recessive inherited dystrophic muscle disease, and 9 children (age: 13+ / -3.35 years) with M . Hecker. the benigne form of Duchenne disease. Both groups exhibited severe forms of paralysis. Muscular protein and neopterin concentrations in serum were compared [0 previously obtained normal ranges, to two healthy controls and a group of 6 children (age: 13 + / -2.76 years) who were exposed to intrauterine hypoxia or hypoxia at birth, without any sign of muscular dystrophy hut myotonia associated with myoclonal spasms. The upper limit of normal serum neopterin levels in children aged<13 years is 13.5 nmol/l.
Cytosolic and structurally hound muscular protein s were highly elevated, up to 40-60 fold increases compared to normals in se ra of M. Duchenne patients, whereas in M . BCl.:ker patients the elevation of these paramenters was approximately up to 20-30 fold compared to health y controls and hypoxic children. No significant differences in neopterin concentrations could be found in M . Duchenne patients (4.5 +/ -0.89 nmol/I) and in M.Becker patients (5.77 + / -2.29 nmol/l) compared to hypoxia induced myopathias (5.10 + / -0.93 nmol/I) and healthy co ntrols (5.55+ / -0.52 nmol/l).
We conclude that there is no evidence of any influence of the immune systeme on the chronic phase of nondystrophic and dystrophic muscle diseases. no differentiation is feasable by neopterin and no connection could be found between alterations of muscular proteins and neopterin. From the data it appears that neopterin may be even lower in Duchenne disease compared to other moypathias. However, more data are needed for a final conclusion.
A Molecular Mechanism for Parkinson's Disease and its Consequences, a Review
Blair JA Pharmaceutical a nd Biological Sciences, Aston University, Birmingham, U.K Parkinson's disease is due to death of the dopaminergic cells of the substantia nigra. The resulting dopamine deficiency causes basal ganglia malfunctioning and motor function loss. Early clinical diagnosis relies on the presence of two of the three symptoms, bradykinesia, rigidity and tremor and a response to L-Dopa.
When unmedicated early Parkinson's patients have significantly reduced plasma levels of 5-methyltetra hydro folate, total biopterins, gallium-transferrin binding, sulphate and sulphate-L-cysteine ratios. Red cell total biopterins are also lowered. Plasma neopterin concentrations are significantly increased. Plasma neopterin and gallium-transferrin binding a re significantly inversely correlated. Gallium transferrin binding significantly correlates with the UP-DRS disability rating scale. Tyrosine hydroxylase activity the probable rate limiting step in dopamine formation is reduced.
On medication with L-Dopa + selegiline plasma and red ceIl total biopterins return to normal levels as does gallium transferrin binding. Circulating immune complexes are normal.
Post mortem brain examination shows activated microglia. plaques and lewy bodies. Normal subjects show a plasma total biopterin rise after oral L-Dopa but a fall when given Nardil, a monoamine oxidase inhibitor.
Elevated neopterin levels in life and the activated microglia seen at post mortem establish Parkinson's disease as one invloving cellular immune reactions. Dopamine is oxidised by monoamine oxidase-B at the outer mitochondrial membrane. The principal inorganic product formed by two electron transfer to oxygen is hydrogen peroxide which is then removed by catalase and/or glutathione reductase. A small fraction of electron transfer occurs as a single electron transfer to oxygen forming superoxide a nion. some of which then form s hydrogen peroxide via superoxide dismutase. The superoxide anion also reacts with nitric oxide forming peroxynitrite which on protonation and homolysis yields the free radicals·OH and NOl . The OH· N0 2 then destroy the cell by attacking the cell membrane and cell components (Scheme).
(two electron transfer) monoamine dopamine . ) aldehyde + H 2 0 2 OXIdase B catalase or glutathione reductase inactive disposal (one electron transfer)
The rise in neopterin is a marker for macrophage activation.
The free radicals ·OH and NO· are powerful oxidants and cause the oxidative loss of biopterin derivatives, the reduction of gallium-transferrin binding NADH loss by oxidation and reduced sulfate formation. Reduced plasma sulphate is also found in Alzheimer's disease, Motor Neurone Disease, Down's syndrome and childhood autism.
Any factor increasing free cytoplasmic dopamine (e.g. change in dopamine transporter) will increase oxidative damage as will increasing one electron leakiness of the flavoprotein MAO enzyme.
As the rate controlling factor in dopamine formation is dietary phenylalanine excess of this essential amino acid must be a major neurotoxin in Parkinson's disease.
The concurrent use of the speCific monoamine oxidase B inhibitor Selegiline must not only increase tissue dopamine but must also reduce the pathological tissue destruction (Scheme). Phenelezine totally abolishes oxidation by aminemonoamine oxidase systems.
The reduction in sulphate levels will alter xeno-
The lowering of gallium transferrin binding indicates a reduction of the entry of zinc but not iron to the brain and would cause neurotoxic effects.
Nitric oxide may combine with the catalytic iron centre in tyrosine hydroxylase and tryptophan hydroxylase deactivating the enzymes and inhibiting the biosynthesis of dopamine, noradrenaline and serotonin. As urine neopterin levels rise urinary zinc output increases.
Biological Role of Neopterin Derivatives
Blair JA, and Pearson AJ University of Aston, Birmingham, B4 7ET, England and Case Western University, Cleveland, Ohio, USA Dihydro-D-neopterin and D-neopterin are found in CSF, plasma and urine. No major biological role has been established for either. Neonates with absent or much reduced pyruvoyltetrahydropterin synthase do not appear to have a toxic · or any other reaction to the large amounts of dihydroneopterin and neopterin present.
Dihydroneopterin is excreted by activated macrophages followed by hydrogen peroxide and is partially oxidised to neopterin. Activated macrophages excrete large amounts of powerful oxidising species which act in phagocytic destruction of infected cells and in apoptosis.
It is suggested that a major role for dihydroneopterin triphosphate is the production of these oxidants (Scheme) and this is the unique function of neopterin derivatives. Steps 2, 3 and 4 are a chain reaction using radical anions derived from tetrahydropterin s. Quantum mechanical calculations show an easy loss of an electron from the HOMO in theSe species, Evidence for this mechanism is: L tetrahydroneopterin has been isolated from natural sources; 2. dihydrofolate reductase and dihydropteridine reductase are present in macrophages; and using tetrahydrobiopterin as a model : 1. NMR studies fail to show any evidence for the alternative C4 hydroperoxy form; 2. kinetic analysis is in accord with the proposed scheme and does not support the alternative C4a hydroperoxy form; 3. superoxide dis mutase inhibits the oxidation reaction; 4. activation energy is low, about 15 kcal. mole.; 5. products of tetrahydropterin oxidation at 4(tc in water are biopterin and dihydrobiopterin; 6. there is a prolonged induction period during which the concentration of the chain carriers (ie pteroyl free radicals) build up, and 7. oxidation rate is reduced by reduction of polarity in the medium.
As there is no low molecular iron species present in the cell, all iron being tightly bound in enzymes, transferrin or ferritin and non-available for Fenton type reactions the formation of hydroxyl radicals by Fenton type reactions from the hydrogen peroxide of reaction 5. or from the elimination of hydrogen peroxide from a C4a hydroperoxide cannot occur.
The superoxide ion formed in reactions 2. and 3. will react with nitric oxide from nitric oxide synthase and the y-interferon induced nitric oxide synthase to give peroxynitrite which on protonation and homolysis yields hydroxyl radicals and nitrogen dioxide radicals without metal catalysis (Scheme reactions 7. and 8). Alcoholic cirrhosis (AC) is accompanied by disturbances of immune function. There exists increasing evidence of activation of the monocyte-macrophage system in this disease as shown by enhanced spontaneous production of cytokines by monocytes and elevated circulating levels of interleukin-l , interleukin-6 and tumour necrosis factor in patients. To further characterize the pattern of cytokine synthesis and monocyte function in AC. we measured serum levels of soluble tumour necrosis factor receptors (sTNF-R) by FLISA (T-cell Sciences) and serum neopterin by radioimmunossay (Henning-Berlin) in 85 patients with AC and 43 controls. Analysis of variance was employed to compare results in patients and controls and spearman's rank correlation analyses to test for association between variables.
In cirrhosis we found significantly elevated serum concentrations of sTNF-R (x± S.D.: 5.7± 7.3 ng/ml, p<O.OI) and neopterin (l1.8± 20.7 nmolll, p<O.Ol) when compared with controls (1.2± 0.53 for sTNFRand 5.01 ± 1.3 for neopterin). There existed a significant correlation between sTNF-R and neopterin in patients (r, = 0.67, p<0.05) and in controls (rs= 0.55, p<0.05).
The increase of both sTNF-R and serum neopterin in these patients reflects the existence of an activated monocyte-macrophage system in AC. The correlation found between serum levels of neopterin and sTNF-R implies that both substances are produced mainly by activated macrophages. Our results contribute to affirm the existence of an immune activation state in alcoholic cirrhosis that could be responsible to the development of the disease and clinical complications. disease progression of human immunodeficiency virus (HIV) infection. Th 1-and Th2-cells, presenting sUbpopulations of CD4+ T-helper cells, characterized by their ability of secreting distinct paterns of cytokines upon stimulation: Th I-cells preferentially produce interleukin-2 and interferon-gamma, thus supporting cell-mediated immune response, whereas Th2-cells produce interleukin-4 and interieukin-lO, supporting humoral immune respof1se. In addition the two types of immune response interfere with each other. activation of Th I-cells slowing down generation and activation of Th2-cells and vice versa.
Increased neopterin concentrations are common in patients with HIV infection. There exist significant correlations between the decrease of CD4+ Tcells and increase of neopterin levels. In addition. serum neopterin concentrations correlate to the replicative capacity of HIV isolates from the patients. Finally, neopterin concentrations predict disease progression. In vitro, large amounts of neopterin are released from monocytes/macrophages stimulated with interferon-gamma. Similarly, a strong correlation between neopterin and interferon-gamma levels has been found in patients with HIV infection. highest levels of both markers of cellular immunity were reported in more progressed stages of HIV infection. Such data demonstrate a significant activation of Th I-type immune response to occur in HIV infection and the activation of TH I-cells being further increasing with disease progression. The obvious discrepancy between findings of neopterin and interferon-gamma in HIV infection and the theory of loss of TH-l type immunity in the course of the disease. is further underlined by the fact that expression of interferon-gamma mRNA is common in circulating T-helper cells m contrast to, e.g., interleukin-4 mRNA.
Whereas in vivo data almost invariably demonstrate chronic activation of Th l-cells, results demonstrating diminished Th I -cells in HIV infection mainly stem from in vitro experiments. diminished response of T -cells to produce interferon-gamma upon antigenic stimulation being one of the hallmarks of HIV infection. Interestingly there exists an inverse relationship between the degree of immune activation and the loss of T-cell proliferative response in vitro suggesting that T-cells are exhausted due to chronic activation in patients and therefore are no longer responding properly to secondary antigens. It appears that chronic stimulation of Th I-cells is involved in the development of tolerance and in the enhanced rate of spontaneous apoptosis. Since particularly Th I-cells are activated, preferentially Th 1-cells will be lost due to programmed cell death. Re-
cent in vitro data demonstrate that HIV itself may be involved to stimulate T-cel1s directly to release interferon gamma, since HIV-gpI20 was shown to stimulate T-cells for interferon-gamma production.
In conclusion, increase of neopterin indicates activation of cellular immunity and of Th I-type immune response. The observations made in HIV infection show an increased activation of Th I-type immune response during the course of infection. Loss of Th I-type immune response can be observed only in response to secondary stimulation with antigens.
Thus, interpretation of in vitro data has to be considered with caution. Further stimulation of Th I cells is not very likely as therapy of HIV infection. In contrast, measures which reduce chronic activation of Th l-cells will probably be beneficial.
Neopterin Concentrations in Vaginal Secretions
Fuith LC*, Kracher P*, Czarnecki M*, Wachter W, In the present investigation we studied the concentration of neopterin in vaginal secretions. Vaginal fluid is easily available and represents the main pathway by which infectious agents invade the intrauterine compartment. A total of 27 vaginal secretions were obtained. 18 samples were collected from healthy women without bacterial vaginosis. 9 samples were obtained from patients with acute vaginitis. After a sample of 10 microliter of vaginal fluid was taken it was dissolved in 1000 microliter 0.9% saline. Neopterin was measured in the vaginal secretions and in the urine of the same patients. Additionally, in order to exclude differences of concentrations in the vaginal fluid. protein was determined in all vaginal secretions. Urinary neopterin concentrations (micromol/mol creatinine) of women without infection (median: 143) and those with infection (median: 148) were statistically not different. Neopterin values in vaginal secretions (nmol/l) in women without infection were above the sensitivity limit in 4 out of 18 cases (mean: 4.2). Neopterin values in vaginal secretions in patients with vaginitis were statistically significantly higher (mean: 40.7; p=O.OOI2, Mann-Whitney Utest). Mean protein concentrations (microgram/ml) in vaginal secretions were similar in both groups. The concentrations of neopterin/ protein (micro mol /g) were significantly higher (p=O.OO44, Mann-Whitney U-test) in patients with vaginal infections (mean: 3668) compared to uninfected women (mean: 225).
In conclusion we found that neopterin concentration in normal vaginal fluid is usually undetectaly low. In case of vaginitis neopterin concentrations in the secretions were significantly higher. Since the urinary neopterin excretion remains unchanged during infection a local neopterin production is conceivable. In this study, fourteen patients with Borrelia burgdorferi infection were investigated for possible abnormalities of the metabolism of tryptophan and neopterin. Four patients (2 were investigated before therapy, 2 when therapy had been already started) had acute Lyme neuroborreliosis. and 10 patients were investigated months to years after acute infection. Increased concentrations of neopterin and of the tryptophan-degradation product kynurenine were detected in the cerebrospinal fluid of 3/4 patients with acute Lyme neuroborreliosis. one patient presented with subnormal tryptophan. Similar changes but to a much lower degree were seen in the treated patients and in some of the patients with Lyme encephalopathy. No such abnormalities were seen in serum of patients. The data point to a role of the immune system and particulary of endogenously formed cytokines like interferon-y and tumor necrosis factor-a. to affect metabolism of tryptophan and neopterin in patients with acute Lyme neuroborreliosis. The biochemical conversion of L-phenylalanine into L-tyrosine is catalysed by the L-phenylalanine-4-monooxygenase, which is able to bind molecular oxygen and transfers hydroxyl groups to the phenyl ring of the substrate. Tetrahydrobiopterin functions as a cofactor and is oxidized to the corresponding quinonoid dihydrobiopterin. In order to get more information about the active site of the enzyme, we are trying to synthesize the 6-(p-azidophenyl)-5,6,7,8-tetrahydropterin, hoping that this photolabile derivative can be bound to the enzyme upon irradiation.
Neopterin Production and Tryptophan Degradation in

Attempts
Our starting material was 6-phenylpterin (1) which was nitrated in the first synthetic approach with nitric acid at O°C leading unexpectedly to an ortho/ para mixture and no meta substitution according to the NMR spectrum. The insolubility of this material was overcome by acylation with isobutyric anhydride yielding 32% of pure 6-(p-nitrophenyl)-N 2 -isobutyrylpterin which crystallized from the reaction mixture. The subsequent catalytic hydrogenation with PtIH2 afforded reduction of the nitro group as well as the pyrazine ring to form the N 2 -isobutyryl-6-(p-aminophenyl)-5,6,7,8-tetrahydropterin. Isolation was achieved by treatment with methanolic HCl to get the more stable hydrochloride salt but leading also to a loss of the isobutyryl group. In order to stabilize the 6-(p-aminophenyl)-5,6,7,8-tetrahydropterin towards oxidizing agents like air or nitrous acid selective protection of the N-5 position by acylation was anticipated. Unfortunately N-5 and the p-amino group at the phenyl moiety turned out to have the same reactivity under a broad variety of conditions leading always to 5-acetyl-6-(p-acetaminophenyl)-5.6, 7,8-tetrahydropterin.
Selective cleavage of the acetamino group generating 5-acetyl-6-(p-aminophenyl)-5,6,7,8-tetrahydropterin was also not successful so that the conversion of the amino group into the azido function via a diazonium salt intermediate could not been achieved.
In a second synthetic approach 6-phenylpterin was converted into 5-acetyl-6-phenyl-5,6,7,8-tetrahydropterin by catalytic reduction and subsequent mild acetylation. Nitration of this intermediate using nitronium tetrafluoroborate looks promising and is presently under investigation. The final steps will include another reduction of the nitro to the corresponding amino group and its conversion into the azido function. Deprotection of the acetyl group by methanolic HCI should form the anticipated 6-(pazidophenyl)-5. Histamine is found especially in mast cells. basophilic granulocytes and thrombocytes. It plays a central role in inflammatory diseases. anaphylaxis and also in immune response because of its activating effect on CD8+ T-cells.
In the monocytic cell line THP-l we investigated the effect of histamine and its selective He-receptor antagonist, cimetidine. on neopterin production after stimulation with interferon-y (IFN-y). Our investigation shows that various concentrations of histamine Preincubation with cimetidine alone and stimulation with 250 Ulml IFN-y did not induce any direct effect, while the addition of cimetidine to a lower dose of IFN-y (100 U/ml) was associated with higher neopterin production than observed with IFN-y alone (not significant). The data would agree with the assumption that cimetidine inhibits effects of eventually endogenously produced histamine.
Similar results as with neopterin formation were observed when the influence of histamine and cimetidine on tryptophan degradation induced by IFNy was examined. Histamine but not cimetidine significantly injhibited the formation of kynurenine. The effect was abrogated when cimetidine was added to histamine.
In sum, we observed a histamine-mediated suppression of IFN-y-induced neopterin formation and tryptophan degradation in the myelomonocytic cell line THP-l. The inhibitory effects induced by histamine could be reversed by addition of cimetidine. Thus. cimetidine may be a potent enhancer of metabolic effects in monocyteslmacrophages induced by IFN-y reversing downregulatory actions of endogenously formed histamine.
The Clinical Use of Cerebrospinal Fluid Neopf.erin Concentrations in Central Nervous Sytem Infections.
Hagberg L Dept of Infectious Diseases. University of Goteborg, Sweden
The spectrum of infectious agents that cause central nervous systemic infections (CNS) are remarkable broad and the clinical spectrum range from acute life-threatning diseases to chronic diseases with little or no symptoms. To follow a CNS infection with predictive markers are often more difficult than in other types of infection sites since lumbar punctures for recashing cerebrospinal fluid (CSF), the closest fluid to the brain. must be performed. Under healthy conditions, CSF show no inflammatory activity and a very low cell count. but CNS infections frequently cause increased CSF cell counts. Counting the number of and characterization of CSF cells are important in differing between viral and bacterial CNS infections. Cytokines and other markers of infectious activity in CSF are under investigation but are not used in clinical practice at present. CSF neopterin concentrations as an indirect measurement of cytokine activity in the CNS was analyzed in varying CNS infections to evaluate its clinical use.
The mean CSF neopterin concentrations were 63.0 nmollI in 15 patients with acute bacterial meningitis, 54.9 nmollI in 15 patients with Lyme neuroborreliosis, 32.5 nmollI in 10 patients with viral meningitis, 131.8 nmollI in 8 patients with viral encephalitis. 13.9 nmollI in 15 patients with asymptomatic HIV infection, 26.0 nmollI in 11 patients with AIDS without dementia, 65.4 nmollI in 4 patients with AIDS dementia, and 4.2 nmol/l in 24 healthy controls. In Lyme neuroborreliosis the patients with the most severe disease had the highest CSF neopterin concentrations. Following antibiotic treatment CSF neopterin concentrations decreased. The CSF neopterin concentration did, however, not add any information of clinical use than determination of CSF mononuclear cell counts and CSF protein concentrations.
In a longitudinally study in 19 asymptomatic HIV-seropositive patients, CSF neopterin concentrations increase from in mean 12.7 to 20.4 nmollI (p< 0.01) with in mean 43 months duration of HIV-l infection. After 3-12 months of zidovudine (AZT) treatment in 8 patients there was a significant reduction of mean CSF neopterin (48%, p<O.OI), which remained at the lower level also during the second year of treatment. No reduction in CSF neopterin concentration were seen after ddl treatment. In patients with AIDS, higher CSF neopterin concentrations were found in patients with opportunistic CNS infection than from patients without such infections.
Conclusions: Although patients with viral encephalitis had higher mean neopterin level than any other patient category studied. the CSF neopterin concentrations could not discriminate between viral and bacterial CNS infections. but may be useful to differentiate between inflammatory and noninflammatory CNS diseases. CSF neopterin was found to be useful to follow a HIV-l CNS infection, which may have important implications for antiretroviral treatment in this patient group.
Is Citation Analysis a Tool for Evaluation of Scientific Contributions?
Hauffe H IUniversity Library Innsbruck. Innrain 50, A-60l0 Innsbruck Initially, the Science Citation Index was designed by its producer, the Institute for Scientific Information, as a bibliographic database which enables the scientist to find references of articles by searching for known articles cited by them. As a side-effect it is possible to perform computer driven statistical analyses of the frequency of citations (i) of an average article of a specific scientific journal (the impact factor) and (ii) of specific articles themselves. There is no doubt, that the more frequently an article is cited the more is is recognized by the scientific community. But, can the figures obtained by these analyses be quoted as indicators for the quality of a scientific journal or an article or a set of articles? In order to decide this question let us consider some factors or biases influencing this correlation both in a positive or negative manner (1-7).
Incomplete citing occurs due to a lack of understanding, a language barrier, a neglection of competiting . authors, the presupposition of "superclassics" , a lack of finding relevant articles, secret research for political or economic reasons, and the inability or unwillingness of an author to "market" his ideas.
In sum, MacRoberts and MacRoberts (7) conclude that authors fail to cite approximately 70% of the influence.
Overcomplete citing may occur due to self citations, courtesy citations, journal biases, former citation biases (the lifting of references), persuasing citations, duty citations, and criticism. In addition, subjects dealing with top actual research fronts and correlated with economic success and industrial consequences, the .. salami science", i.e. dividing the results of a single study into two or more papers and republishing the same results in successive papers, and unjustified authorship (there are authors who did not see the final version submitted to the journal) may cause overcomplete citing.
Furthermore, there are different potentials or chances for being cited. These depend on the size of the readership in special fields: Members of a small scientific community can cite fewer thematically interesting articles than members of a large one (8). Therefore the impact factor as an obsolute figure even if it is put in relation to the journal's circulation may not be used as an indicator of a journal's quality. It remains simply and literally a factor describing the impact of its journal or the impact of an average article published in it. But, the conclusion from the impact of an average article to a particular one is not logically stringent: an analysis of the citation rate for all articles published by a single author over a 17-year period showed no correlation with the impact factor of the journals where they were published (9). This is not an argument not to try to place a paper in a high-impact journal; of course it then has a higher chance to be read and to be recognized.
So, analyzing directly the citation rate of an individual article or of an author's publications is a more suitable method for measuring its impact than the anonymous participation with the impact factor of a journal. In fact, the conclusion may be drawn that a highly-cited article must be of high quality too; but, in my opinion the reverse inference is not permitted. Citation analysis may be a good measure for sociologic studies in science, but the measure is far from perfect to evaluate the quality of scientific work.
Furthermore, the feedback between the items to be measured and the measurement method itself influences the evaluation: Authors who are aware of this methods may take advantage of their competitors. The feedback leads authors to try to publish high-quality papers in high-impact journals, but the scientific community is also intersested in reading high-quality articles in low-impact journals, e.g. those read by non-publishing and therefore non-citing people like general practitioners or physcians working outside the universities. This does not mean that citation analysis cannot be used as one of many indicatiors in evaluating individuals; it cannot replace peer reviewing which published papers are read and evaluated by expert'> within the same field. Chemistry and Biochemistry, University of Innsbruck. Austria
As uveitis is an inflammation of the eye and inflamatory cells can reach the inner parts of the eye, it might be possible that the information of a developing or existing disease can be detected in the periphery.
In this preliminary study 34 uveitis-patients were included. Treatment was performed depending on the severity of inflammation with either systemic or topical corticosteroids. Some patients were followedup for three time-points at different stages of the disease. 58 serum-neopterin-values were investigated and were correlated with clinical, etiological, pathological and other parameters.
From anterior uveitis suffered 18 patients, ten had intermediate and five had posterior uveitis. Acute uveitis developed in 26 patients and eight patients had chronic uveitis. HLA -B27 + associated uveitis were nine cases, two were classified as sarcoidosis and 23 were idiopathic. In 28 cases one eye had an inflammation, in six cases both eyes were involved. Almost all measured neopterin values lay in the range of normal controls. There see'llS to be no difference between a chronic or an acute phase of inflammation before or after treatment Patients with sarcoidosis had higher detectable neopterin-values than patients with other systemic diseases (HLA-B27 + associated) or with idiopathic uveitis, No significant differences were detected if one or both eyes were inflamed. Before treatment neopterin values of posterior and pan-uveitis lay higher than of anterior and intermediate uveitis; after treatment only the values of posterior uveitis were lower than before.
Form our preliminary data it is yet too early to draw definitive conclusions. We found that most of the tested sera had low neopterin-Ievels. High serumneopterin-levels were associated with sarcoidosis. There seems to be a trend that higher neopterin levels reflect a more severe grade of intraocular-inflammation. Pathogenetic mechanisms involved in HIV related diarrhoea and wasting remain poorly defined. We therefore investigated determinants of villus shortening, together with serum neopterin, in a group of 68 Zambian AlDS patients with chronic diarrhoea, and 10 controls. All underwent anthropometric assessment, stool parasitology, and endoscopic Jistal duodenal biopsy on the same day.
Serum Neopterin Concentrations in Zambians with
Serum neopterin concentrations were much higher in the diarrhoea patients than in Zambian TB patients following treatment (mean 61 nmollI vs median 21 nmol/l). Villus height was reduced in patients compared to controls (mean 210 vs 304 urn; p= 0.(02). Villus height was not related to body mass index (BMI), but related to mid upper arm circumference (p=0.02) and sum thickness of three skin pinches (S3PT; p = 0.(02). Increased inflammatory infiltrate was found in 97% of biopsies from diarrhoea patients: plasma cell in 89% and eosinophil in 11%. There was no effect of parasitosis upon biopsy appearances. Intraepithelial lymphocyte (lEL) counts were increased in patients vs controls (p = 0.01), and inversely related to villus height (p=O.Ol).
Serum neopterin concentrations were higher in patients with elevated IEL counts (70.2 vs. 38.5 nmollI; p= 0.(05), and higher in patients with a ratio of IgG:albumin in duodenal aspirate of > 1.0 (p = 0.04). They were not significantly related to villus height, nor to parasitosis. Neopterin concentrations also reflect nutritional state (S3PT; p=0.(02) and Kamofsky score.
We conclude that serum neopterin is related to nutritional state and to intestinal inflammation. and is greatly elevated in patients with HIV related diarrhoea in Africa.
Regioselective Alkylation of Pteridine by Grignard Reagents
Kenji Kiguchi,* Shizuaki Murata,* and Takashi Su-;imoto t *Graduate School of Human lnfonnatics. and t Department of Natural Science Informatics. School of Informatics and Sciences. Nagoya University Chikusa, Nagoya. 464-0\ Japan Direct introduction of substituents on 6 or 7 posilion of pteridines seems to be the most straightfor-\\ ard process for naturally occurring ptelidines. We '1ave already shown utilities of the conceptually new :'rocess on syntheses of Asperopterin-B and related :'leridines by using alkoxyl and acyl radical substi-:·.ltion (1. 2). Described herein are regioselective a\-kylation reactions of pteridines by Grignard reagents.
Addition of Grignard reagent to 3-amino-4-butoxypteridine (1) afforded 7-alkylpteridine 2 after protonation followed by iodine oxidation. The reaction proceeded regioselectively, but yields of 2 were unsatisfactory (6-21%) (3).
Oxidation of 1 by H 2 0 2 in CF 3 COOH selectively gave 8-oxide 3 (52% yield), the C(7) position of which is activated toward nuclephilic attack. Reactions of 3 with excess Grignard reagents occurred in THF at 25"c to give a mixture of 2 and 8-oxide 4. the latter was converted to the former in quantitative yield by (CH 9 )3P. Therefore, this procedure is an improved method of 2 from 1 (yields: 10-50%). Despite its low incidence septic arthritis remains a serious problem in orthopaedic practice. General or local immunosuppression predisposes for septic arthritis. Thus we see an increasing incidence in elderly patients, in patients suffering from rheumatic diseases and after alloplastic arthroplasty of the hip and of the knee.
In septic arthritis the first line of host defense mechanisms is ovelwhelmed and bacterial mUltiplication proceeds within the joint. The pathogens found are in 50% to 75% of cases Staphylococci and in 15% to 20% Streptococci.
Histologically we initially find an edema of the synovial membrane and a dramatic polymorph-nuclear-cell inftltration. Mter developing all signs of inflammation, a persistent purulent effusion accumulates and cartilage and bone destruction ensues as a result of proteolytic enzyme activity released from the polymorph nuclear leukocytes. Modem therapy consists of an early surgical intervention (synovectomy, debridement) combined with local and systemic antibiotic treatment. The early intervention is one of the main factors for a successful management.
Thus the interest of an early detection of septic arthritis is obvious. The production of neopterin can be related to the activity of the specific antibacterial cell mediated immune response.
In the current study we examined neopterin levels in 12 patients with septic arthrits and in 8 patients with an infected prosthesis. The results were related to a new inflammation marker (PMN-elastase) and to 4 other • classical' inflammation markers (ESR. leukocytes, fibrinogen and C-reactive protein). All markers showed a high sensitivity in the detection of septic arthritis.
11 patients with septic arthritis and all 8 patients with an infected prothesis showed pathological neopterin levels> 10 nmol/1. Neopterin was analysed in commercially available HIV-l seroconversion panels using ELISA and RIA methods. Conflicting results obtained for some samples may be due cither to degradation of neopterin or to poor test performance. In four panels raised neopterin concentrations associated with HIV-l p 24 antigen peaks during early seroconversion were found, and in a low titer performance panel consisting of sera from 10 HIV seroconverters neopterin concentration was found to be correlated with p 24. In 6 out of 30 sera of HIV-l low titer and HIV-l/2 mixed titer panels neopterin concentrations were> 10 nmol/l. We also found neopterin concentrations> nmolll associated with CMV IgM, but not with CMV IgG in 3 out of 25 sera of an anti-CMV mixed titer performance panel.
These findings confirm that neopterin is raised The prognostic value for cancer patients depends on several factors including variables which characterize the tumour itself The host's immune response appears to be critical in controlling the development and the further progression of malignant growth.
Retrospectively we investigated clinical factors, morphometric features and urine concentrations of neopterin, a marker for macrophage activation, in 68 ovarian carcinoma patients. About 50% of our patients showed neopterin concentrations above the cut-off level of 275 umol/mol creatinine. Nuclear roundness was a good predictor of patient survival. Interestingly. those patients with elevated urinary neopterin concentrations, and thus displaying a sign of activation of cell-mediated immunity. had a shorter survival than those with a normal concentration. Applying a multivariate cox regression analysis. the only independent parameters predicting patient survival were FIGO stage. residual disease. nuclear roundness and neopterin.
The data show worse prognosis in patients with ovarian cancer to be associated with higher neopterin concentrations. this implies an association between higher degree of cellular immune activation and adverse outcome. Since 1986 to the end of 1993 c. 350,000 blood donations have been screened for neopterin (in addition to the usual required tests). Neopterin-measurement was routinely performed with a commercially available Radio-Immuno-Assay (RIA). Recently Enzyme-Immuno-Assays (ELISA) have been described. We have evaluated a new commercially available ELISA for it's suitability of screening voluntary blood donations. The assay was performed on 1040 consecutive blood donations and results were compared with RIA and, in 142 samples, also with High Performance Liquid Chromatography (HPLC). On repetitive assays of all donations exceeding 8 nmol/L in the initial assay, three of the RIA results were identified as gross outliers. No such outliers were detected in the ELISA. Regarding the reproducibility of results exceeding the cut-off limit of 10 nmol/L neopterin (cut-off for exclusion of blood donations), the ELISA was better than the RIA. Even compared with HPLC, ELISA was slightly better than RIA (based on linear regression analysis, evaluation of frequencies of concentrations exceeding 10 nmol/L and construction of Receiver Operated Characteristics). We thus conclude that this Enzyme-Linked Immuno Sorbent Assay is well suited for screening neopterin concentrations in blood donations. It's slight superiority over the conventional Radio Immuno Assay has to be discussed through employment of higher degree of automatization (which is not easely achieved with RIA). Information obtained from the electron micrographs is used to determine the crystal packing, i.e. the translational and rotational position of the crystal lattice. X-ray and electron microscope data suggest that the enzyme is a decamer with D5-symmetry. The images of the ab-plane of the citrate crystals clearly reveal the package of the particles in this plane. This information can be used to facilitate the interpretation of the X-ray diffraction data. Acute myocardial infarction (AMI) is characterized as a necrosis of the myocardium caused in most cases by an occlusion of a coronary artery, and associated with systemic inflammatory reaction marked by an increase in circulating monocyte-derived cytokines (e.g. interleukin-6) and acute phase proteins. Disorders of cellular immunity have been also described, and may lead in some patients to an autoimune process known as dressler's syndrome. We have measured urinary neopterin in 13 patients presenting with AMI. Neopterin levels at admission were only slightly higher than in the reference group (221± 116 vs 152± 50 J..Imol/mol creatinine, not significant). However, within a week., neopterin excretion showed a remarkable rise to a mean of 399± 205 J..Imol/mol creatinine, which was significantly higher with respect of both the reference group (MannWhitney U test, P<0.OO3) and the initial values (Wilcoxon test for matched pairs, P<0.02). Neopterin excretion then declined to 232± 122 J..Imol/mol creatinine at discharge in 2-3 weeks (Wilcoxon test, P <0.01 compared to peak values).
Urinary Neopterin Excretion in Acute Myocardial
We conclude that systemic inflammatory phenomena in AMI a re not restricted to monocyte-derived cytokines and may also include activation of cellular immunity reflected by increased urinary neopterin levels.
Effect of Granulocyte-macrophage Colony Stimulating Factor Administration on Urinary Neopterin
Melichar B,I Solichova 0. In recent years. recombinant human granulocytemacrophage colony stimulating factor (GM-CSF) has found widespread use in clinical hematology for the treatment of neutropenia or as differentiation therapy. Although the granulocyte or monocyte progenitor cells are the main targets of this cytokine, some effects on mature cells and the immune response have been also described. We have measured urinary neopterin in 6 patients both before and after GM-CSF administration (150-600 ug daily by subcutaneous injection for 4-9 days). Urinary neopterin was significantly higher in the patients than in the controls (355± 136 vs 128± 32 J..Imol/mol creatinine, Mann-Whitney U test, P<O.Ol) and rose further significantly after the treatment (546± 180 J..Imol/mol creatinine, Wilcoxon test for matched pairs. P<0.05). The rise was observed in all 6 patients. Although the synthesis of neopterin has been demonstrated to be controlled mainly by interferon-gamma, an increase in neopterin concentrations has been observed after administration of many cytokines including interleukin-2, interferon-alpha, interferon-beta or interleukin-3. As with these cytokines, elevated neopterin synthesis after GM-CSF may be explained by both direct activation of macrophage or by the =-,-:jines ! Vol. 5 / No.2 release of other cytokines.
We conclude that GM-CSF appears to possess a measurable immunostimulating activity which is reflected by increased neopterin levels and could be important therapeutically.
Molybdenum Cofactor Biosynthesis in
The aim of this research is the molecular and biochemical description of a new metabolic pathway in plants that is of relevance to perhaps all eukaryotes. The moybdenum cofactor (Moco) is a component common to all molybdoenzymes with the exception of nitrogenase. It was shown to be a low-m.w. molybdopterin exhibiting no catalytic activity on its own but becoming biologically active on association with an appropriate apoprotein. Nitrate reductase is the most important plant molybdoenzyme followed by xanthine dehydrogenase. The molybdoenzymes sulfite oxidase and aldehyde oxidase occur mainly in animals, pyridoxal oxidase and xanthine oxidase are important for insects, and several different molybdoenzymes are known in bacteria. The Moco has three general characteristics: *Unique in structure which is similar in all organisms so far examined. *Universal in function in that it forms part of the catalytically active center of very diverse enzymes thus catalyzing reactions on C-, S-and N-atoms, *ubiquitous in occurrence in that it occurs in all living organisms ranging from bateria to humans and plants. Moco mutants have been described in bacteria, fungi, algae, mosses, plants, insects and humans. The mutants biochemically and genetically best characterized in higher eukaryotes, were generated in the tobacco species Nicotiana plumbaginifolia where at least six genes (cnxA to cnxF) were found to be involved in the sythesis of active Moco. The detailed biochemical and genetic analysis of the cnx mutants led to a first working for the pathway of Moco biosynthesis.
Using genetic complementation of E. coli chI mutants (being defective in the Moco) by plant cDNA expression libraries (tobacco. Arabidopsis thaliana). a first cnx gene could be isolated. On the protein level, homologies to a mammalian neuroprotein of higher than 40% were found (in humans a mutation in Moco is sublethal and leads to severe brain damages during embryogenesis causing mostly death after birth).
Neopterin Enhances
In previous studies, we have shown that neopterin, 6-D-erythro-trihydroxypropyl-Pteridine, synthesized by human monocytes/ macrophages upon stimulation by interferon-y, enhances toxicity of reactive oxygen at neutral or siightly alkaline pH (7.5), but not at acidic pH(S:6.5 In the present study. we have explored in more detail necessary requirements for neopterin to modulate the effects of hydrogen peroxide in a luminol-dependent chemiluminescence assay. We demonstrate that neopterin enhances hydrogen peroxide effects only in presence of iron chelator complexes like iron-(lIl)-or iron-(II)-EDTA or iron-(III)-DTPA. Thus, iron chelator complexes together with neopterin may play an important role in macrophage-mediated effector mechanisms. Interestingly the necessary requirement of iron is only valid when using hydrogen peroxide as radical productor. In chloramine T-induced luminol-dependent chemiluminescence the enhancement by neopterin is independent from the presence of iron chelator complexes. Completely different are the effects of 7.8-dihydro-neopterin: Both hydrogen peroxide-induced and chloramin T-induced luminol-dependent chemiluminescence are scavenged independently from pH value and the presence of iron chelator complexes.
In is tempting speculate that macrophages increase their extracellular cytotoxicity of hydrogen peroxide by release of neopterin. Which is only active at neutral pH. while macrophages are protected against intracellular da mage by the acidic pH. The crystal structure of rat liver-6-pyruvoyl tetrahydropterin synthase has been solved by multiple isomorphous replacement and refi~ed to a crystallographic R-factor of 20.4% at 2.3 A resolution.
6-pyruvoyl tetrahydrobiopterin synthase catalyses the conversion of dihydroneopterin triphosphate to 6-pyruvoyl tetrahydropterin. the second of three enzymatic steps in the synthesis of tctrahydrobiopterin from GTP
The functional enzyme is a hexamer of identical subunits. The 6-pyruvol tetrahydropterin synthase monomer folds into a sequential, four stranded. antiparallel f3-sheet with a 25 residue, helix-containing insertion between strands I and 2 at the bottom of the molecule and a segment between strands 2 and 3 forming a pair of antiparallel helices. layered on one dide of the f3-sheet.
Three 6-pyruvoyl tetrahydropterin synthase monomers form an unusual 12-stranded antiparalle f3-barreI by tight association between the N-and C-terminal f3-strands of two adjacent subunits. The barrel encloses a highly basic pore of 6-12 A diameter.
Two trimers associate in a head-to-head fashion to form the active enzyme complex.
The substrate binding site is located close to the trimer-trimer interface and comprises residues from three monomers A A' and B. A metal binding site in the substrate binding pocket is formed by the three histidine residues 23, 48 and 50 from one 6-pyruvoyl tetrahydropterin synthase subunit. Close to the metal, but apparently not liganding it. are residues Cys42. Glu133 (both from A) and His89 (from B), which might serve as proton donors and acceptors during catalysis. NeopteIin, a pteridine delivative, is secreted by activated macrophages and serves as a marker for activation of monocytes-macrophages. Neopterin concentrations are found to be raised in a number of maliquant disorders, and in certain malignat diseases neopterin concentrations significantly predict prognosis.
In this study we examined serum concentrations of neopterin, beta-2-microglobulin and lactate dehydrogenase as well as clinical pa rameters such as age, histology, clinical stage, weight loss, B-symptoms, performance status, bone marrow involvement. bulky disease and extranodal involvement in 41 patients. Pretherapeutic measurements of serologic parameters together with a complete staging workup were performed. Correlation with survival was determined. Treatment consisted of COP-or CHOP-like regimens with or without radiotherapy. Neopterin showed higher significant correlations than beta-2-microglobulin with clinical stage, weight loss and performance status. Both parameters did not correlate with histologic grading. Significnat correlations existed between the different signs of endogenous immune activation: neopteIin concentrations correlated with beta-2-microglobulin, LDH and erythrocytes sedimentation rate. LDH did not correlate with clinical staging and weight loss. Patients having a refractory disease defined as never documented to be in a complete remission had a worse prognosis coceming survival. Lower neopterin concentrations were associated with higher probability for response to treatment and remission than higher levels.
Tuberculous Bone Infections -Monitoring of Treatment by Neopterin Determinations
Peters KM,I Schweitzer K 2 Zimmermann S,i Zilkens KW 1 iClinic of Orthopaedic Surgery, RWTH Aachen, 2Institute of M edical Immunology, RWTH Aachen Elevated levels of neopterin are related to activity in cell-mediated immune response (T ceIl/ macrophage system) and are found especially in infections caused by viruses and intracellular bacteria and parasites. In patients with ~uberculosis caused by intracellular MycobacteIia elevated n eopterin levels could be found as well. Hasp et al. measured serum neoptelin concentrations in patients with tuberculous chest infections, 55% of them being sero-positive for HIV type I as well. Serum neopterin was elevated in HfY positive group in 95%, in HIV-negative group Tuberculous bone infections often occur decades afte r primary chest infection or Tb infection is even unknown in history. Clinical symptoms are often unspecific and it can last weeks before cultures are positive for MycobacteIia. I n our current study we wanted to evaluate neopterin as a marker for the detection and the monitoring of treatment of tuberculous bone infections.
In 8 patients (6 women, 2 men, age: 25-85 years) with specific osteomyelitis (2Xcoxitis, 6Xspondylo-discitis) the following biochemical markers were measured in serum: neopterin, CRP, fibrinogen, ESR. WBC. In all cases tuberculosis was proven by positive cultures and histology, respectively. In 6 cases Mycobacterium tuberculosis was found as infectious agent. in 2 cases Mycobacterium avium intracellulare. All patients received tuberculostatic therapy, two of them combined with surgical treatment.
In 4/5 patients levels of neopteIin and CRP were initially elevated, whereas the other acute phase protei n fibrinogen was normal in 4/ 5 cases. In all patients ESR was moderately increased, WBC within normal range. Neopterin was especially a helpful marker for the monitoring of treatment with tuberculostatic drugs. After a sufficient treatment of tuberculous bone infections neopterin levels decreased and remained within normal range. In one patient with a bone infection caused by M. avium intracellulare being resistent against the given tuberculostatic therapy neopterin was persistently elevated (27 nmol/l), whereas CRP was only slightly elevated (9.9 mg/I). In another patient with tuberculous coxitis initially M. tuberculosis was found as infectious agent. After 6 months of tuberculostatic therapy neopterin was still slightly beyound normal range (10-12 nmol/l)' CRP was not elevated. In a second biopsy of the infected hip resistant M . avium intracellulare was found as well.
Neopterin seems to be a helpful m a rker for the drug monitoIing of patients with tuberculous bone infections. After a sufficient tuberculostatic therapy initially elevated neopterin levels decrease and remain within normal range. Persistent elevation of neopterin may be a hind for a resistance of the Mycobacteria . Two of the enzymes of the de novo purine biosynthesis pathway utilize reduced folate co factors as the source of one carbon units required in building the purine ring. The first of these. glycinamide ribonucleotide formyltransferace (GARFT). requires lO-formyltetrahydrofolate as the cofactor. and supplies the eventual purine 8 carbon. In E. coli. there also exists an additional GARFf activity which utilizes an alternate carbon source. The folate dependent GARFf, a monofunctional polypeptide in bacteria. is part of a trifunctional protein in higher organisms. along with two other enzymes of the pathway. Our laboratory as well as others has cloned. sequenced and expressed the GARFT domain of the human trifunctional protein. The kinetics of the catalytically active expressed domain a re identical to those of the trifunctional protein isolated from human cells. indicating that the domains function independently. The affinity of substrates and inhibitors of GARFT is markedly enhanced by polyglutamylation. Modeling studies based upon the crystal structure of GARFf suggest several positively charged surface a mino acid residues as candidated for the polyglutamate binding region. Site-directed mutagenesis of these to neutral species has been done. and lowers polyglutamate binding.
The other folate-requiring enzy me of the pathway is aminoimidazolecarboxamide ribonucleotide formyltransferase (AICARFf). which adds the eventual purine 2 carbon. Throughour evolution AlCARFf is prese nt on a bifunctional protein along with IMP cyclohydrolase. These enzy mes catalyze respectively the penultimate and final steps of the pathway. In contrast to GAR FT. there is no known non-folate-dependent alternate AICARFT. Our laboratory has recently cloned. sequenced and expressed human AICARFT/ IMPCHasc. The sequence is about 75% homologous to tl',c previously know avian enzyme. Since there are no bacterial monofuctional counterparts. domains cannot be readily discerned. Deletion mutagenesis. however. gave an N-terminal 250 aa fragment which possessed IMPCHase. but lacked AICARFr activity. Some subtle sequence homologies with GARFT suggest that the fornlyltransferase activity lies in the C-terminal portion of the protein. Whereas dihydro-and tetrahydro-pterins are potent scavengers of radical-induced reactions. aromatic neopterin was found recently to be a very strong enhancer of such reactions. For example. addition of neopterin greatly enhances the light output of a luminol-dependent chemiluminescence assay using reagents like hydrogen peroxide or chloramine-T. and the addition of neopterin to a disinfectant like chloramine-T strongly increases the cytotoxic potential of such a disinfectant against. e.g .. E. coli bacteria. In a first attempt to elucidate the mechanisms behind these observations, a series of 26 different derivatives of the pterin and lumazine series was tested for its effects on the luminol-dependent chemiluminescence induced by chloramine T. All experiments were performed at 37°C and pH = 7.5 and using a pteridine concentration of 100 !-lmol per liter. Three groups of compounds were identified. A first group of strong enhancers comprised (in decreasing strength of the enhancing effect) biopterin. neopterin. dictyopterin. monapterin. 04-methyl-biopterin. bioiumazine. neolumazine, 6(l'.2',3',4'-tetrahydroxybutyl )-pterin. 6-hydroxy-methyl-pterin and 3-N-methyl-biopterin. A second group B of strong scavengers comprised (in decreasing order of scavenging effect) 7.8-dihydro-neopterin. 7.8-dihydro-neolumazine. sepiapterin. 7.8-dihydro-6-hydroxy-lumazine and leukopterin. The remaining 11 compounds h ad weak enhancing [ptel;n-6-carboxylate. 7-biopterin. pterin-7-carboxyla te. isoxantho-pterin. 6-methoxymethyl-pterin. 6-( I' -oxo )-propyl-lumazine, pterin. N.Ndimethyl-neopterin and 6-mehtyl-pterin] or scavenging effect (xanthopterin and I-N-methyl-pterin. To get a first idea which molecular properties might influence the hehaviour of pteridine derivatives in a chemiluminescence experiment. ab initio quantum chemical calculations (Hartree-Fock method. 6-31 G ** basis set) were done on all compounds followed hy Mulliken population analysis in order to derive the atomic partial charges. These computed charges were then related to the observed effect of the substances in the chemiluminescence assay, and a linear discriminant model could be established which was able in a Jackknife validation to predict the enhancing or scavenging behaviour of all but two substances correctly. This model involves the partial charges on atoms N5. C7 and N8. However. further work needs to be done to clarify the mechanistic role of pteridines in radical-induced reactions. (6RI'R2'S)-5,6,7,8-Tetrahydrobiopterin is an essential cofactor for several enzymes. Different authors using different theoretical models (molecular mechanics. semiempirical quantumchemical calculations) have investigated the stereostructure and have found diverging answers. To clarify these issues, ab initio quantum chemical calculations were performed on both the axial and the equatorial side chain orientation of the molecule. After generating a multitude of chemically reasonable low-energy conformations by an expert system approach and after geometry optimization of each of these conformers by molecular mechanics. full geometry optimization within the Hartree-Fock framework was performed on the resulting structures with the lowest energies. The geometries thus resulting were subjected to systematic variation of two side chain torsional angles in order to study the conformational flexibility. The results suggest that (i). the structure with axial side chain orientation is slightly more stable than the equatorial form (by 2.2 kcal per mol); (ii). a weak intramolecular hydrogen bonding interaction exists between the hydrogen atom bonded to N " and the oxygen atom at C e ' : (iii) a second hydrogen bond involving the oxygen atom at C 4 and the hydrogen atom bonded to the oxygen atom at C e ' contributes to stabilization of the most stable conformer; and (iv), both the pseudoa:cial and the pseudoequatorial structure possess sufficient conformational flexibility as to prevent save prediction of one distinct predominant conformation. These results were further extended by subjecting the molecules to a molecular dynamics simulation without. and with the inclusion of 81 water molecules in order to study temperature and solvent effects. These simulations showed that P lcriJ in c"' s / Vol. 5 / No.2 the tetrahydrobiopterin molecule possess sufficient conformational flexibility to break the weak intramolecular hydrogen bonds via the occurrence of bond rotations. While the axial orientation of the most stable from of the compound remains stable in the presence of water molecules surrounding it, a simulation in vacuo at 310 K temperature also exhibits ring conversions; i.e .. the side chain changes it orientations during the temporal evolution of the system. Speculations attributing to conformational properties only the unique specificity of important enzymes for the natural cofactor tetrahydrobiopterin should therefore be regarded with extreme caution. Neopterin concentrations in serum and urine have been described in several cancers to carry significant predictive power: high concentrations are associated with poor survival of patients. In this study, survival analysis was performed on 72 patients with lung cancer on whom urinary neopterin and other routine clinical and laboratory variables had been measured at the time of diagnosis. The fate of the patients had been followed up to more than 10 years. In a first analysis it was shown that neigher neopterin nor the other laboratory variables were associated with important clinical indicators of the diseases such as. e.g .. tumor stage. grading. lymph node status and morphologic type of the malignancy. When testing separately each variable for its univariate association with prognosis (measured by time from diagnosis to death) by the product-limit approach. all clinical variables (tumor stage, lymph node status, grading. occurrence of distant metastases and general well-being) except one (morphologic type) were significant predictors of death. In contrast. of all laboratory variables only neopterin was ahle to yield predictive information (P=0.OOI3). Alkaline phosphatase (P=0.092). hematocrit (0.21), gamma glutamoyl transpeptidase (0.22). hemoglobin (0.42), white blood cell count (0.44). aspartate aminotransferase (0.84), serum urea (0.91), thrombocyte count (0.92) and serum protein (0.96) were not related with prognosis. Multivariate analysis by Cox regression technique identified a combination of three clinical (ly-mph node status. P = 0.OOO3; tumor stage. P=O.OOO6; grading, P=0.0047) and one laboratory variable (neopterin. P = 0.0047) to provide jointly the best predictive information. This was underscored by testing the predictive power of neopterin in subclasses of patients defined by important clinical predictors. For example, patients with lymph node status NO (i.e .. without malignant inflltration of lymph nodes) showed a lO-year survival probability of slightly above 50%. Patients of this group who had a neopterin value below the third quartile value of 324 /lmol per mol creatinine has a lO-year survival rate of about 70%; in contrast all patients of this group whose neopterin exceeded this cut-off value, died within less than four years after diagnosis. In other subgroups, similar observations were made regarding the extra predictive power of neopterin concentrations. Thus, lung cancer can be added to the list of malignancies in which neopterin provides a simple means of improving predictive classification of patients.
Neopterin is a Significant and Independent Predictor in Lung Cancer
Synthesis of Pteridine-modified Oligodeoxyribonucleotides
Rosier A and Pfleiderer W Fakultiit fur Chemie. Universitat Konstanz. 0-78464 Konstanz/Germany Lumazine (1,2) and isopterin 2'-deoxyribonucleosides (3) can be regarded as structural analogues of thymidine and 2'-deoxycytidine, respectively. Glycosylations of lumazine and its 6,7-dimethyl and 6,7-diphenyl derivatives with 35-di-0-acyl-2-deoxy-ribofuranosyl chloride lead always to an a.j3-anomeric mixture of the corresponding N-l substituted nucleosides. Separation of the isomers can be achieved either by fractional crystallization or by chromatographical means.
Deprotection gave good yields of the 1-(2-deoxyj3-D-ribofuranosy) lumazines 1-3. The monomeric building blocks for oligonucleotide synthesis were then prepared by standard methods used in nucleic acid chemistry. Treatment with dimethoxytrityl chloride in pyridine gave 5'-OH protection and further reaction with l3-cyanoethoxybis-N-diisopropylamino-phosphane under tetrazole catalysis resulted in the formation of the fully blocked 3'-O-(j3-cyanoethyl, N-diisopropyl) phosphoramidites in high yields. The corresponding 3' -O-hernisuccinates were also prepared from the intermediary 5'-0-dimethoxytrityl derivatives by reaction with succinic acid anhydride and were then coupled to a specially modified controlled pore glass material (LCMAA) (4) which was functionalized with a terminal methylamino group. A series of selfcomplementary as well as mixed oligonucleotides carrying the normal purine and pyrimidine bases were assembled in a DNA-synthesizer very efficiently. T m-measurements of these duplexes indicated that the introduction of one lumazine moiety at the 3'-and 5'-terminal end, respectively. influences the hybridization only very little whereas the substitution of a thymidine residue inside the oligonucleotide chain by a lumazine-2'-deoxynucleoside unit causes a decrease of the Tm of 5 degrees in the case of lumazine and interestingly only one degree in presence of 6,7-diphenyllumazine (5). In the last years many different immunologic parameters have been described being helpful to monitor renal posttransplant patients. All of these parameters like neopterin. CRP. gamma-interferon. IL-2. soluble-IL-2 receptor, TNF. eirculating ICAM-I have been shown to increase during graft rejection and during infectious diseases.
In order to evaluatc which kind of immunological parameter would fit best to be installed as routinely used parameter after kidney transplantaion we compared 6 parameters: neopterin, CRP, gamma-interferon, soluble-IL2 receptor, circulating ICAM-l and soluble TNF-receptor.
We studied 70 kidney graft recipients over a period of 5 months, 29 patients showed a stable graft function during the study period, 16 patients showed at least one rejection episode, 6 suffered from CMV infection, 6 from CMV infection and acute graft rejection and 13 from other complications (bacterial infection in 4 cases, acute renal failure in 7 cases, surgical problems in 2 cases). All of these measured parameters did not differ significantly from healthy controls during stable graft function. There was a significant increase of neopterin during acute graft rejection (from 14.6± 10.8 to 40.7± 32 ng/mL p<0.05), CMV infection (13.6± 11.2 to 28± 11.9 ng/mL p< 0.05) rejection plus CMV infection (14.4 to 57.6± 38, p<0.02). There was also a significant increase of s-TNF-R during acute graft rejection (from 11.9± 9 to 25.8± 11 ng/ml, p<O.OI) CMV infection (22.9± 8 ng/ml, p<0.05) and rejection plus CMV infection (22.7± 7 ng/ml, p<0.05). Soluble IL-2R concentrations increased during acute rejection from 1476± 867 U/ ml to 4l77±2338 U/ ml (p<O.OI) and during CMV infection to 7072 U/ ml (p<O.Ol). The changes of ICAM-I, CRP and gamma-interferon during rejection of infectious episodes were less pronounced and did not reach statistical significance. Soluble IL-2R and s-TNF-R seem to increase I to 2 days before the onset of clinical rejection providing an opportunity for early diagnosis and treatment. But one has to take into account that these parameters are unspecifc and tend to increase also during infectious episodes. Nevertheless we conclude that the findings of elevated s-TNF-R s-IL-2R and neopterin supports the diagnosis of transplant rejection and may be important to differentiate graft rejection from cyclosporin nephrotoxicity and to rellect the response to antirejection therapy. Wegener's granulomatosis (WG) is a disease of unknown origin and characterized by necrotizing granulomatosis lesions, which usually first affect upper and lower airways. This limited form can tum into a generalized vasculitic disease leading to necrotizing crescentic glomerulonephritis, pulmonary capillaritis, and constitutional symptoms such as fever and weight loss. Currently, there are 3 laboratory markers that are considered to reflect clinical activity in WG: C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and antineutrophil cytoplasmic antibodies (ANCA). Unfortunately, ESR CRP and ANCA levels do not always correlate with disease activity. Hence, new markers of WG activity must be sought.
The purpose of the study was to define a possible association between different markers of immune activation and to disease activity in patients with WG.
Thirty five patients with WG (14 male, 21 female, mean age 39± 11 years) were studied. All patients fulfilled ACA criteria (1990) for classification of WG. Birmingham vasculitis activity score (BVAS) was used for calculating disease activity (mean index II ± 10). Serum neopterin was measured by RIA (Henning-Berlin). Serum soluble TNF (sTNF-R, 55 kDtype) and IL-2 (sIL2-R) receptors, and serum soluble ICAM-l (sICAM-l) were determined by ELISA (T Cell Sciences).
Compared to the 95th percentile of healthy controls, neopterin and sTNF-R concnetrations were increased in 54% and 58%, sIL2-R in 47% and sICAM-l in 35%. There were significant correlations between the BVA score and serum neopterin (rs= 0.55), sIL2-R (r=0.56) and sTNF-R (rs=0.56; all p< 0.00 I). There existed also significnat correlations between neopterin and sTNF-R (r5=0.83, p<O.OOOI) or sIL2-R (rs = 0.66, p<O.OOl).
In conclusion, elevation of serum neopterin, s1L2-Rand sTNF-R concnetrations is associated with disease activity in WG patients. The purpose of the study was to define possible association between different markers of immune activation and disease activity in patients with BD.
We studied 38 patients with BD (26 male, 12 female. mean age 32± 8.01). All patients fulfilled the criteria for the diagnosis of BD of the International Study Group for Behcet's Disease. Five patients had mild activity of disease, 23 moderate and 10 severe. Neoptelin was measured by RIA (Henning-Berlin). Serum soluble TNF (sTNF-R, 55kD-type) and ILl (sIL2-R receptors and soluble ICAM-I (sICAM-I) were determined by ELISA (T Cell Sciences).
The mean serum neopterin concnetration in BD patients was 8.7± 4.1 nmol/L (4.9-20.6). Compared to the 95th percentile of healthy controls, neopterin and sICAM-I concentrations were increased in 50% and 57%, slL2-R in 26% and sTNF-R in 16%. There existed significant differences between mean neopterin or sICAM-I levels in patients with moderate (8.5 ± 3.2 nmol/L 439± 98 UIL) and severe (13.2± 4.3 nmol/L, 535± 129 U/ L) activity of BD (p<0.05). Similar differences were found for patients with positive and negative pathergy test.
Our study shows that activation of the cellular immune system takes place in patients with BD. The activity of BD is associated with increase of serum neoptetin and sICAM-l. High neopterin and sICAM-1 levels in patients with positive pathergy test suggest a role of cytokines in skin hyperreactivity and in the pathogenesis of vascular injury. Angiotensin-converting enzyme (ACE) activIty is elevated in a variety of jiseases. e.g .. sarcoidosis and huma n immunodeficiency virus infection a nd increased ACE activity is associated with poor prognosis. The mechanism of increased ACE is not well known. Captopril is an ACE inhibitor which influences the immune system by a mec hanism involving monocytes and macrophagcs.
We examined the in vitro effect of pure captopril (Bristol-Myers Squibb) on the formation of neopterin and tryptophan degradation in monoc:1ic THP-I cell lines stimulated by interferon-y (lFN-y). In addition. we investigated a possible role of IFN-'( to stimulate ACE activity in the same cells. THP-l cells were seeded at 6 X IOsl ml in 2+\\C'! 1 plates and treated with stimuli for 72 hours Ih}. If',;-Y was applied at 250 U/ m!. Captopril (1.25 ~g. mL , and fosinoprilat (I ~/mL) (Bristol-Myers Squibb) were added before IFN-y and then evely 24 h. Determination of neopterin in supernatants was carried out by RIA (Henning-Berlin). kynurenine by HPLC. ACE activity was measured in the pellet by a colorometric assay (Buhlmann. Switzerland).
Captopril did not influence neopterin synthesis when added alone. However. the mean neopterin and kynurenine levels were higher when combining IFN-y plus captopril as stimulus compared to IFNy alone (p<O.OO I). Also the mean ACE activity was increased after IFN-y stimulation (l0± 0.3 U/6X 10" cells) compared to controls (5.9± 0.3 U/6X 10'; pS 0.05). Captopril and fosinoprilat inhibited ACE activity in controls and after IFN-stimulajtion (pSO.05). There was no significant correlation between ACE activity and neopterin (p>O.I).
Captopril influences neopterin formation in macrophages when applied in combination with IFN-y, and IFN-y induces ACE activity in macrophages. ACE and neopterin are independent markers of macrophages activation. The ability of human immunodeficiency virus (HIV) to replicate in CD4 + T lymphocytes and mononuclear phagocytes is influenced by immunoregulatory cytokines. A central role for tumor necrosis factor alpha (TNF alpha) in the course of HIV infection and AIDS has been postulated. However, cytokines are rapidly cleared from the circulation and long-term markers have to be analyzed. Two distinct TNF alpha receptors (sTNFR 55 and sT-NFR 75) have been identified, which also exists in soluble fonns, and are considered to reflect TNF alpha activity. Neopterin is a sensitive marker for endogenous fonnation of interferon gamma.
We investigated 63 individuals with HIV infection for serum levels of TNF alpha, sTNFR 75 and urinary neopterin. The study popUlation comprised all stages of HIV infection. Circulating levels of TNF alpha were detectable in 22 of 63 (34.9%) individuals. For those with detectable TNF alpha levels the median concentration was 40 pglmL. The frequency and extent of TNF alpha levels found in those with advanced HIV infection as defined by a CD4 + T-cell count below 320X 10 6 L did not differ from those with a higher CD4+ T-cell count. Increased concentrations of sTNFR 75 were found in 87.3%. Urinary neopterin concentrations were outside the nonnal range (above 200 Ilmol/mo1 creatinine) in 60 of 63 individuals. The correlation found between sTNFR 75 and urinary neopterin (r5=0.52, p< 0.00(1) was stronger than that of sTNFR 75 with TNF alpha (rs 0.45, p=O.OOO4).
We further investigated 60 individuals with HIV infection (representing all stages of HIV infection) for serum levels of interferon gamma, sTNFR 75 and urinary neopterin. Compared with the upper nonnal limit of 100 U/L (25), 49 of 61 individuals (93.4%). Interferon gamma correlated with sTNFR 75 and urinary neopterin similarly (r, =0.51, p= 0.00 (1) .
The mechanisms of the increase in concentrations of sTNFRs remain to be elucidated. Shedding of sTNFRs may be induced from endogenously fonned TNF alpha. However, it may also be upregulated by endogenous interferon gamma. Increased concentrations of interferon gamma have been found in the majority of HIV seropositive individuals, however, increase of neopterin concentrations was more sensitive than changes of interferon gamma. Neopterin release from macrophages is primarily under the control of inferferon-gamma, however, TNF alpha synergistically amplifies macrophages for neopterin secretion. The correlation found between the sTNFR 75 and urinary neopterin was stronger than for TNF alpha. This findings suggest that increased concentrations of sTNFR 75 in HIV infection are linked to immune activation where synergistic actions of interferon gamma and the TNF alpha system are liely to play an important role.
TNF alpha has been shown to up-regulate HIV expression in chronically HIV infected T-and monocytic cell lines. Only recently it has been shown that interferongamma is also able to induce the ex- Since 1986 to the end of 1993 appro 350,000 blood donations have been screened for neopterin (in addition to the usual required tests). 1060 stored specimens from the year 1991 with elevated neopterin were tested on PARVOVIRUS-BI9-lgM-ANTIBO-DIES to find out a correlation between Parvovirusinfections and neopterin. From these 1060 specimens with raised neopterin levels 73 (6.9%) were found parvovirus-lgM-Ab-positive incontrast to a control group of 462 specimens (nonnal neopterin levels) with 2.2%.
It was also possible to test 987 from the 1060 specimens on EPSTEIN-BARR-VIRUS-lgM-ANTIBO-DIES: from these 987 specimens with elevated neopterin 54 (5.5%) had EBV-lgM-Antibodies (in a control group with 502 specimens 2%).
Six specimens were positive for both, Parvovirus B19 and EBV, IGM-Antibodies.
These results are statistically significant. In the group of neopterin elevated specimens we can find an almost three times higher prevalence of EBVIgM-Ab or Parvovirus-B19-1gM-Ab compared with the control groups. In the first step of the tryptophan catabolism, indoleamine (2.3-) dioxygenase (100) catalyzes the cleavage of tryptophan to N-fonnyl-kynurenine, which is then further degraded to kynurenine. The increased endogenous fonnation of interferon-gam-rna not only leeds to enhanced neopterin concentrations in body fluids, but also activates IDO resulting in an increase of tryptophan degradation. As a consequence increased kynurenine levels and higher kynurenine/tryptophan (= KT) ratios as well as a decrease of tryptophan can be detected in individuals during cellular immune response. During pregnancy a significant increase of neopterin levels was demonstrated in serum and urine. In this study we examined serum neopterin, tryptophan and kynurenine concentrations in 36 healthy pregnant women (of various gestational age) and 20 healthy nonpregnant female controls of corresponding age.
Neopterin levels of nonpregnant women (median 4.85 nmollL; interquartile 4.15-5.0) were lower than those of pregnant women (median 5.8 nmollL; interquartile 4.6-7). Kynurenine concentrations in nopregnant controls were higher (median 1.3 flmollL; interquartile 1.2-1.5) than those of the pregant women (median 1.2 flmollL; interquartile 1-1.3). There were significantly lower tryptophan levels in pregnant women (2nd trim.: median 51 flmollL; interquartile 48.6-55.6 3rd trim.: median 46.2 flillollL; interquartile 33-50) compared to nonpregnant controls (median 56.5 flmollL; interquartile 51.9-63.1). In some women tryptophan concentrations were extremely low. KT ratios were lower in nonpregnation than in pregnant women in the 3rd trimester, but lowest in the 1st trimester.
Several significant correlations existed between duration of pregnancy and lower tryptophan as well as higher neopterin levels and higher KT ratios. In addition significant correlations were found between the levels of neopterin and tryptophan, as well as neopterin and the KT ratio.
Conclusion: A higher degree of neopterin formation and tryptophan degradation is observed during pregnancy. Cellular immune activation is likely to be the cause of these biochemical changes. We wonder whether abonormally low tryptophan concentrations may be associated with abnormalities of neurotransmitter biosynthesis which may contribute to e.g. memory loss or other neuropsychiatric disturbances in pregnancy. In our study, we compared the level of serum neopterin, interleukin 6, and sTNF-R in 26 patients with multiple myeloma (MM) including 2 patients with monoclonal gammopathy of unknown significance (MGUS), in 15 patients with chronic lymphocytic leukaemia (CLL), 2 patients with hairy cell leukaemia (HCL), 12 patients with Non Hodgkin's lymphomas (NHL), 16 patients with Hodgkin's disease (HD). The mean neopterin level in the serum of all patients was 14.1 nmoll1, however levels ranged from 3.7 to 77 nmoill. In 9 of 15 CLL patients, in 11 of 26 patients with MM, wheras only in 4 of 12 patients with NHL and in 5 of 16 patients with HD neopterin levels were beyond 10 nmoll1.
In the CLL group the highest levels of neopterin were found and correlated with disease progression (levels between 34.5 and 77 nmol/l). In HD disease, neopterin levels correlated clinically with B-symptoms (fever, weight loss, night sweat). In the NHL group the highest levels were found in the goup of centrocytic NHL (39.2 and 62.7), whereas all high grade NHL constantly showed low neopterin levels. In the MM group, there was only one patient with excessive neopterin levels and the neopterin levels did not correlate with stage and course of disease.
Interleukin-6 levels did not correlate signifanctly with the neopterin levels and with the clincial course either. In the MM group 16 of the 24 tested patients displayed elevated interleukin 6 levels, 7 of the 15 CLL patients, 6 of the 8 tested patients with NHL with in part excessive elevated levels (268 ng/ml, normal value <3 ng/ml), however with no association to disease activity. s lNF-R correlated with the serum neopterin levels, however was less sensitive than serum neopterin. There was no correlation . with the interleukin 6 levels. The highest slNF levels were found in CLL patients like observed with serum neopterin.
Our data demonstrated that the most significant correlation of serum neopterin with progressive disease occurred in the CLL group and it is intruiging that it ha~ been shown the interteron-y which stimulates neopterin secretion is responsible for inhibition of apoptosis in CLL and therefore augmenting the number of tumor cells resulting in disease progression.
Neopterin is in HD disease and NHL a marker for systemic symptoms, however has less association with tumor load and stage of disease in patients with multiple myeloma. The clinical role of interleukin 6 has to be furhter elucidated, since its increase did not correlate with neither the clinical course nor with the neopterin levels.
Plasma Nitrate Levels in Experimental Bacteremia in Baboons
Strohmaier W, Werner ·E*, Redl H, Wachter H.*, Schlag G Ludwig Boltzmann Institute for Exp and Clin Traumatology, Vienna, Austria, *Dept of Med Chern and Biochem, University of Innsbruck., Austria
In a recently developed model of bacterially induced sepsis in baboons we were interested to study the time course of nitrate levels with regard to dose dependency and low dose lNF-antibody treatment. Two groups received a 2 hr infusion of 2 X 10 8 CFU live E. coli kg BW (group LOW, n=8), and 2X 109 CFU/ kg BW (group HIGH, n = 6). A third group (lNF -ab, n = 5) was treated with a low dose of lNF-ab 2 hrs prior to E. coli infusion similar to group HIGH. Nitrate levels remain at baseline (~20 f..U1101/l) up to 4 hrs, but then increase 3-4 fold within the next 20 hrs in groups HIGH and lNF-ab. Group LOW reveals unchanged concentrations throughout the experiment. In contrast., lNF and endotoxin levels peak at 2 hrs and decline towards baseline at 8 hrs iII all groups. To see if there is a correlation between NO-release and hemodynamics, we compared the changes in systemic vascular resistance (SVR) with those found for nitrate. Groups HIGH and lNF-ab show a significant decrease for SVR between 0 and 24 hrs, while group LOW shows no difference. However, it remains speculative in how far elevated NO-release influences Pteridines Recently, it was reported that mtnc oxide (NO) directly inteIferes with intracellular iron metabolism by activating iron responsive factor (IRF), a cytoplasmatic protein, thus regulating ferritin and transferrin receptor mRNA translation. To determine whether intracellular iron levels themselves interact with NO synthase (NOS), we studied the effect of iron on cytokine-inducible NOS activity and mRNA expression in the murine macrophage cell line 1774A.L We show here that NOS activity is decreased by about 70% in homogenates obtained from cells treated with IFN-y plus lipopolysaccharide (IFN-y/ LPS) in presence of 50 11M ferric ion (Fe3+) as compared to those from cells treated with IFN-y/LPS alone. In contrast., addition of the iron chelator desferrioxamine (100 !lM) at the time of stimulation with IFN-y/LPS increases NOS activity up to 4-fold in 1774 cells. The effects of these drugs cannot be attributed to a general alteration of the IFN-y/LPF-signat since they did not influence IFN-y or IFN-y/LPSmediated MHC class II antigen expression. Furthermore, neither intracellular availability of the NOS cofactor tetrahydrobiopterin was altered by treatment with FeC+) or desferrioxamine, nor did these compounds inteIfere with the activity of the hemoprotein NOS. In contrast., cytoplasmatic mRNA levels for NOS were drastically increased by treatment with desferrioxamine and reduced by Fe(3+ ). Half life of NOS mRNA in the cytosol, as determind in the presence of actinomycin D , is not altered by ferric ion. With desferrioxamine a slight but not significant prolongation of mRNA stability in the cytosol was obselved. Nuclear run-off experiments indicate that desferrioxamine and ferric iron modulate nuclear transcription for cytokine-inducible NOS mRNA which may be responsible for the changes in the enzyme activity. Our results suggest an autoregulatory loop for iron and NO/NOS: low levels of intracellular low molecular weight iron increase NOS mRNA transcription, thus stimulating NO formation. As a result, ferritin translation is decreased and transferrin receptor mRNA stability and consecutively translation is increased by NO-mediated activation of iron responsive factor, which specifically binds to iron responsive elements (IRE) at the 5' -untranslated region of ferritin mRNA and 3'-untranslated region of transferrin receptor mRNA respectively. This might upregulate intracellular levels of non-ferritin-bound iron which in tum reduces NOS mRNA transcription and consecutively inactivates iron responsive factor. In order to get a new tool to investigate the binding of pteridines to nitric oxide synthase, we synthesized 3'[3HJ6R-5,6,7,8-tetrahydrobiopterin from 8, 5'[3HJ guanosine 5-triphoshate (GTP) using the three biosynthetic enzymes GTP-cyclohydrolase I (E. C. 3.6.4.l6), 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase (E.c. 1.1.1.153). GTP-cyclohydrolase I was purified from an E. coli strain (kindly donated by A. Bacher and C. Schmid. Technische Universitat Munchen) carrying a plasmid containing the gene for E. coli GTP-cyclohydrolase I under control of the lac repressor. After expression of the gene with isopropylthiogalactoside, the enzyme is purified by ion exchange chromatography. 6-Pyruvoyl tetrahydropterin synthase from Drosophila melanogaster (I) was a kind gift of JJ. Yim, Department of Microbiology, University of Seoul, Korea. Sepiapterin reductase was partially purified from rat liver by ion exchange, hydrophobic interaction and gel filtration chromatography. After incubation of 8,5'[3HJGTP with GTP-cyclohydrolase I, 6-pyruvoyl tetra hydropterin synthase and sepiapterin reductase in presence of NADPH and Mge+), the product is purified by ion-exchange high performance liquid chromatography. Whereas the 8[3HJ-Iabel is lost in the GTP-cyclohydrolase I reaction. the 5'[ lHJ-label could be incorporated into the product with 50% theoretical yield, i.e. 25% of the total radioactivity was incorporated into tetrahydrobiopterin. The product was chemically and radiochemically pure(> 95%), with a specific activity of 9 Ci/mmol. It proved well suited for studying the pteridine binding site of nitric oxide synthase. In previous work we showed that pteridine biosynthesis is stimulated by interferon-gamma in a number of human cell types including macrophages, endothelial cells and fibroblasts. We further observed, that bacterial lipopolysaccharide (LPS) stimulated neopterin release in human macrophages, endothelial cells and in the myelomonocytic cell line THP-1. In order to assess which components of LPS mediate this effect, we tested various parts of this molecule for their ability to induce neopterin formation in THP-I cells. Since the action of LPS depends in part on serum components, e.g. the presence of LPS-binding protein, we applied the bacterial cell waJl components in absence or presence of fetal calf serum (FCS). LPS from smooth bacterial strains (Escherichia coli serotype 055:B5 and serotype 026:B6, Salmonella typhimurium, Klebsiella pneumoniae), rough strains (E. coli) EH 100. E. coli F583, (Rd [2] ), Salmonella minnesota Re595 (Re), Salmonella typhimurium), detoxified fatty-acid-free LPS (E. coli 055:B 5. S. minnesota, S. typhimurium), diphosphoryl lipid A (E. coli F583. S. minnesota Re595), monophosphoryl lipid A (E. coli F583, S. minnesota Re595), fatty-acid-free lipid A (D-acetamido-6-0-(2-acetamido-2 -deoxy-~-D-gi ucopyranosy 1)-2 -deoxy-D-gi ucopyranose). and KDO (2-keto-3-deoxyoctonate) were compared. Further. cell wall components from gram-positive bacteria were tested: lipoteichoic acid from Staphylococcus aureus, N-acetyl muramyl L-alanyl Disoglutamine and trehalose 6.6' -dimycolate, both used as adjuvants in Freund's adjuvant and isolated from Mycobacterium sp., and an exotoxin from Staphylococcus aureus, i.e. toxic shock syndrome toxin TSST-l. We found that only the complete LPS molecule stimulates neopterin formation to a degree comparable to interferon-yo whereas lipid A is only weakly active and requires the presence of FCS. This suggests that a serum component may be involved in the effect of lipid A on neopterin fonnation of THP-I cells. However, in combination with interferon-y, lipid A as well as polysaccharide moieties from LPS were able to potentiate the interferony effect Also cell wall components from gram-positive bacteria and TSST-I costimulate interferon-y-induced neopterin formation and, when used as single stimuli, induce neopterin release at low levels independently from the presence of FCS. We are currently investigating which signal transduction pathways are involved in the effect of bacterial cell wall components on macrophage activation. In 80 sera from 53 patients with spoardic amyotrophic lateral sclerosis we quantitated neopterin, 13r microglobufin, immunoglobulins IgG, IgA, IgM and IgG isotypes IgG 1 , IgG2, IgG3, and IgG4. Mean age at first signs or symptoms of ALS was 55 years, mean age at first measurement 57 years. As in other populations. age at measurement correlated positively with serum neopterin (0.08 nmol*L -I/year± 58) without sex difference (mean neopterin 5.8 nmol± 1.8 SD at mean age of 57.2 years). Neopterin correlated well with 132-microglobulin (mean 132M 1.56 mg/L± 0.4 SD), and mean neopterin did not change after age-adjustment (5.87 nmollL± 1.6 SO). In 19 patients died until now, serum neopterin and overall duration of disease in months correlated inversely with (r= -0.49, p<0.05) and without correction for age. Neopterin did not correlate with duration of ALS at time of measurement expressed as percent of total survival. Simultaneously quantitated immunoglobulins associated neither with cellular immune parameters nor survival. If confinned in more patient courses under evaluation, a longer survival with lower serum neopterin would resemble the more markedly negative correlation in acquired immunedeficiency syndrome after human immunodeficiency virus infection. 125 years after its first description of ALS by Charcot 1869, surrogate parameters for therapeutic studies are still urgently needed. Hydroxy-, mercapto-and amino-substituted pteridines are very little soluble in water and organic solvents due to strong intennolecular hydrogen-bonding and aggregate fonnation. Chemical syntheses are therefore difficult and purification of the reaction products tedious and tim-consuming. In order to overcome these difficulties new protecting groups have been introduced to increase the solublities especially in organic solvents. Since protection of the amide function is most effective we applied the Mitsunobu reaction to Nl-acetyl-pterin (1) using p-nitrophenyl-ethanol, triphenylphosphane and ethyl azodicarboxylate for the alkylation. The reaction product was identified as 2-acetamino-4-p-nitrophenylethoxypteridine (8).
9Ot: for 24h.
In the lumazine series, the 1-(16) and 3-methyl derivative (17), respectively, proceeded only with Nalkylation to 18 and 19. The p-nitrophenylethyl (npe) protecting group turned out to be a very versatile blocking group in pteridine synthesis since it forms relatively stable and well soluble intermediates. Final deprotection of the npe group can be achieved under mild conditions with DBU in a qunatitative ~-elimination process. The new strategy allows also structural modifications of more complex pteridine derivatives such as biopterin and neopterin which are presently under investigation. For sTNF-R a value of >8.1 ng/mL included all cases of neoplastic and malignant changes within cyst (group IV): 46 of 51 cases (90.1%) with benign changes (groups I and V) showed sTNF-R levels at or below 8.1 ng/mL. A cut-off value of 11 nM neopterin included all cases of group IV, 41/50 (82.0 %) of cysts with benigne changes (groups I and V) had values below this level. Unlike simple cysts, high neopterin levels in group V, not correlating with low levels of sTNF-R and sIL-2R in the same patients, were found. On follow up, the benign course in group V was predicted by lower levels of sTNF-R and sIL-2R only.
Low sTNF-R and neopterin (below the cut-offs used) were not associated with malignancy. In groups II-IV all three parameters supplied similar information showing significant elevation in comparison to group I (p<O.OOl).
We conclude that low levels of sTNF-R, sIL-2R and neopterin have high negative predictive value with regard to premalignant or malignant degeneration 0 thyroid pseudocysts. The parameters should provide further valuable information for the management of this disorder. Balance studies of ingestion and excretion reveal-ed that more than three quarters of nitrogen oxides (nitrite and nitrate) excreted originate from endogenous synthesis from the guanidino nitrogen of L-arginine. This line of research finally lead to the characterization of a cytokine-inducible form of nitric oxide synthase. Tetrahydrobiopterin is a limiting cofactor of both cytokine inducible and constitutive forms of nitric oxide synthase, and inhibition of pteridine synthesis has been shown to attenuate NOmediated cytotoxicity in vitro (l). Nitric oxide (NO) is a highly active molecule involved in e.g cytotoxicity, vascular relaxation and neurotransmission. In the body, NO reacts with e.g. oxygen or superoxide to nitrite, which is converted to nitrate by oxyhaemoglobin.
Increased concentrations of neopterin have been found in body fluids of patients with diseases challenging the cell mediated immunity, e.g. malignant diseases, allograft rejections and viral infections including HIV -I-infection.
We found increased levels of nitrite + nitrate in 110 HIV-I-infected indivijduals compared to 76 blood donor controls (p=0.03). If the HIV-I-infected individuals were divided into subgroups according to the number of CD4+ T cells, nitrite + nitrate levels in those with CD4+ T cells above 500IIlL (stage 1) did not differ significantly from the control group whereas those with CD4+T cells 200-4991IlL (stage 2) or CD4 + T cells below 200//lL (stage 3) did (p = 0.06 and p=0.02 respectively). These differences become more pronounced when nitrite + nitrate levels are related to creatinine (p=O.OOI for stage 2, p= 0.002 for stage 3). Serum neopterin is markedly increased «(p=O.09 stage 1, p<O.OOOI stages 2 and 3). Serum biopterin concentrations, however, are not significantly different from blood donor controls (p> 0.1 for all stages).
The most striking feature of the data is a correlation of serum concentrations of nitrite + nitrate with neopterin (rs=0.39, p<O.OOI). This correlation remains significant when applied to the subgroups defined by the number of CD4+T cells (stage 1: rs= 0.36, p=O.04; stage 2: r, =0.37, p=0.02; stage 3: rs= 0.46, p = O.OO4). In the group of blood donors nitrite + nitrate levels did not correlate with neopterin (rs = 0.12, p>O.I). Biopterin levels did not correlate with nitrite + nitrate levels neither in blood donors nor in the HIV-I-infected individuals. Only a weak correlation was found between biopterin and neopterin levels (rs = 0.24, p = 0.01).
Since neopterin is known to correlate to interferon-gamma levels in HIV-l infection in vivo, and since interferon-gamma is a key trigger in the induction of both GTP-cyclohydrolase I and NO synPleridines I Vol. 5 I No.2 thase aCtIVIty in vitro, a straightforward interpretation of these correlations is the assumption of cytokine triggered increase in pteridine and NO synthesis in HIV-I infection. Lack of increase of serum biopterin and lack of correlation of serum biopterin to nitrite + nitrate levels is probably caused by a better retention of tetrahydrobiopterin as compared to neopterin derivatives inside cells and tissues (2) . These results suggest cytokine-mediated increased nitric oxide formation in infection with HIV-J. The increased NO formation in HIV-l infection may explain several observations made, e.g. correlation of neopterin with iron metabolism (3), which in vitro has been shown to be altered by NO-mediated regulation via iron responsive elements on the translational level (4).
Possible Influence of Inhibitory Factors Causing Anemia in Myelodysplastic Syndromes
Zwierzina H , Artner-Dworzak E, Gallati H, Herold M, Wachter H, Fuchs D The myelodysplastic syndromes (MDS) represent a clonal disorder of an early hemopoietic progenitor cell leading to abnormal maturation of all hemopoietic cell lines. The FAB (French-American-Britain) group classified the MDS according to bone marrow (BM) myeloblast count in refractory anemia (RA) and RA with ring sideroblasts (RAS; hoth BM blasts <5%), RA with excess of blasts (RAEB; 5-20% BM blasts), and RAEB in transition (RAEBt 21-30% BM blasts). MDS patients are mainly elderly individuals and prognosis is correlated with BM blast cell count and the possibility of transition to overt leukemia on the one hand, and with (pan-) cytopenia leading to an increased risk of lethal infections, bleeding, or the aggravation of pre-existing ischemic disorders on the other. In contrast to acute leukemia where normal hemopoiesis is overgrown by the malignant process, MDS patients may present with expressed (pan-) cytopenia without major increase of BM blasts. This led us to the hypothesis. that negative regulatory factors produced by the malignant clone may play a crucial role in the pathogenesis of cytopenia in MDS.
We investigated in 38 patients with MDS (13 RA/RAS; II RAEB; 14 RAEBt) serum levels of potential negative regulatory factors like macrophage inhibitory protein la (MIP-Ia) and tumor necrosis factor a (TNFa) including its soluble receptors (sT-NFF-R55 and sTNF-R75). We tried to correlate these data with serum neopterin levels. peripheral blood cell count and MOS stage according to F AB classification.
A correlation p<O.05) was detected among TN Fa. sTNF-R55, sTNF-R75 and neopterin. Neopterin also correlated with MIPI and platelet count. Neither MIP-Ia or TNFa nor neopterin did correlate with monocyte or lymphocyte count.
While monocyte count did not differ between RAlRAS and RAER it was significantly decreased in RAEBt. Serum levels of negative regulatory factors. however. were not decreased in RAEBt suggesting that monocytes in progressed. MDS are functionally activated. This may indicate that inhibitory factors are maximally released by monocytes in progressed MOS with the aim to inhibit the malignant clone, but also produce severe cytopenia.
Hemopoietic growth factors like granulocyte-macrophage colony-stimulating factor (GM-CSF) or interleukin-3 (IL-3) are investigated in clinical trials in MOS. It remains to be determined whether these factors stimulating the monocyte/macrophage system are also able to induce the release of negative regulatory factors in vivo .
